Skip to content

BillionToOne, Inc. BLLN Fair Value Adjustment Of Term Loan

Fair Value Adjustment Of Term Loan at other companies

Taysha Gene Therapies, Inc. logo
Taysha Gene Therapies, Inc.TSHA
$32K-87.5%
Taysha Gene Therapies, Inc. logo
Taysha Gene Therapies, Inc.TSHA
$1.47M-3.9%
CubeSmart logo
CubeSmartCUBE
-$210K-1,650%
loanDepot logo
loanDepotLDI
-$6.54M-156%
Trilogy Metals logo
Trilogy MetalsTMQ
$1.51M-73.2%
Century Communities logo
Century CommunitiesCCS
-$3.2M+31.2%

Other financials

Income statement

See full
Revenue$108.4M+83.8%
Gross profit$79.1M+108%
Operating income$17.8M+870%
Net income$18.0M+551%
EPS (diluted)$0.34+187%

Balance sheet

See full
Cash & equivalents$537.5M+181%
Total debt$144.2M
Total equity$505.6M+300%
Total assets$700.7M

Cash flow

See full
Operating cash flow$15.4M+488%
CapEx$4.5M+90.5%
Free cash flow$11.0M+3,842%

Valuation

See full
Market cap$5.16B+17.3%
Enterprise value$4.77B
P/E174.1×
P/S14.6×

Profitability

See full
Gross margin70.4%
Operating margin-96.9%
Net margin8.4%
FCF margin-83.4%

Returns & leverage

See full
Return on equity23.5%
Debt / equity0.3×
Current ratio10.9×

Where this comes from

Reported directly by BillionToOne, Inc. in its filing.

Tagged under the XBRL concept blln:FairValueAdjustmentOfTermLoan.

The official record: BillionToOne, Inc. ’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about BillionToOne, Inc. 's fair value adjustment of term loan.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is BillionToOne, Inc. 's fair value adjustment of term loan?
BillionToOne, Inc. (BLLN) reported fair value adjustment of term loan of -$2.78M in Q1 2026.
How has BillionToOne, Inc. 's fair value adjustment of term loan changed year-over-year?
BillionToOne, Inc. 's fair value adjustment of term loan decreased by 54.6% year-over-year, from -$1.8M to -$2.78M.
What does fair value adjustment of term loan mean?
Measures the non-cash gain or loss resulting from the periodic revaluation of term loan obligations carried at fair value. This adjustment is necessary to reconcile net income to operating cash flow by removing the impact of market-based debt valuation changes. It provides clarity on the underlying cash-generating ability of the business.